Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal nalbuphine dose for preventive analgesia in laparoscopic cholecystectomy
ChiCTR1900027609Phase 4Recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine in postoperative pain (3 arms), sponsored by Huai'an Second Hospital. Primary endpoints: Numerical Rating Score, Extubation time and 1 more. Started Nov 2019; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1900027609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027609.